DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • France
  • /
  • Healthcare
Author Program NEWCreate Narrative
CLARI logo

Clariane SE Stock Price

ENXTPA:CLARI Community·€1.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CLARI Share Price Performance

€4.00
-0.01 (-0.30%)
​
€4.66
Fair Value
€4.00
-0.01 (-0.30%)
14.2% undervalued intrinsic discount
€4.66
Fair Value
Price €4.00
AnalystConsensusTarget €4.66
AnalystHighTarget €5.10
AnalystLowTarget €4.70
Thu, 18 Jun 26
Fair Value€4.66
Share Pricen/a

CLARI Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value €4.66 14.2% undervalued intrinsic discount

Refinancing And French Pricing Will Pressure Margins But Build Resilience

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value €5.1 21.6% undervalued intrinsic discount

Aging Demographics And Digital Tools Will Fuel Resilient Recovery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value €4.7 14.9% undervalued intrinsic discount

Rising Debt And European Regulation Will Hamper Eldercare

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CLARI logo
Clariane
14.9% undervalued intrinsic discount

Rising Debt And European Regulation Will Hamper Eldercare

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 2 Jul
Read Narrative
CLARI logo
Clariane
14.2% undervalued intrinsic discount

Refinancing And French Pricing Will Pressure Margins But Build Resilience

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 18 Jun
Read Narrative
CLARI logo
Clariane
21.6% undervalued intrinsic discount

Aging Demographics And Digital Tools Will Fuel Resilient Recovery

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 3 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
CLARI logo

CLARI: Hybrid Notes Refinancing Will Test Support For Elevated Future P/E

Fair Value: €4.7 14.9% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
CLARI logo

CLARI: Higher P/E Assumptions Will Drive More Constructive Share Price Outlook

Fair Value: €4.66 14.2% undervalued intrinsic discount
7 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
CLARI logo

CLARI: Brand Strength And Margin Focus Will Support Future Re Rating

Fair Value: €5.1 21.6% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Fair value with moderate growth potential.

2 Risks
4 Rewards
View Full Analysis

Clariane SE Key Details

€5.4b

Revenue

€3.7b

Cost of Revenue

€1.7b

Gross Profit

€1.7b

Other Expenses

€12.6m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.035
31.28%
0.23%
113.2%
View Full Analysis

About CLARI

Founded
2001
Employees
70685
CEO
Sophie Boissard
WebsiteView website
www.clariane.com

Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. In addition, it offers medicalized nursing homes and alternative living solutions, such as shared houses, assisted living, and domiciliary care, as well as outpatient consultations and diagnostics, and social care services. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.

Recent CLARI News & Updates

Recent updates

No updates

Clariane SE Competitors

EMEIS logo

emeis Société anonyme

Symbol: ENXTPA:EMEIS
Market cap: €2.0b
GDS logo

Ramsay Générale de Santé

Symbol: ENXTPA:GDS
Market cap: €1.2b
EQS logo

Equasens Société anonyme

Symbol: ENXTPA:EQS
Market cap: €468.3m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide